NASDAQ : NSPR
InspireMD, Inc. — Financial statements
Healthcare · Medical Devices · United States
Last price 0.45 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 20.92M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
InspireMD, Inc. (NSPR) reported revenue of 10.84M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 10.84M | 8.98M | 7.01M | 6.21M | 5.17M | 4.50M |
| Cost of Revenue | 8.88M | 6.33M | 5.50M | 4.40M | 4.05M | 3.74M |
| Gross Profit | 1.96M | 2.65M | 1.51M | 1.81M | 1.12M | 754.00K |
| Selling, General & Admin | 39.35M | 37.26M | 21.38M | 14.97M | 12.02M | 10.31M |
| Research & Development | 16.17M | 15.00M | 13.63M | 7.98M | 7.81M | 5.16M |
| Operating Expenses | 55.52M | 52.26M | 35.01M | 22.95M | 19.83M | 15.47M |
| Operating Income | -53.56M | -49.61M | -33.50M | -21.14M | -18.71M | -14.72M |
| Interest Expense | -157.00K | |||||
| Interest & Investment Income | 1.14M | 891.00K | 1.56M | 1.29M | 250.00K | |
| EBT Excluding Unusual Items | -52.42M | -48.72M | -31.95M | -19.85M | -18.46M | -14.87M |
| Pretax Income | -52.42M | -48.72M | -31.95M | -19.85M | -18.46M | -14.87M |
| Income Tax Expense | 63.00K | 63.00K | 59.00K | 65.00K | 28.00K | 45.00K |
| Net Income | -52.48M | -48.79M | -32.01M | -19.92M | -18.49M | -14.92M |
| Net Income to Common | -52.48M | -48.79M | -32.01M | -19.92M | -18.49M | -14.92M |
| Shares Outstanding (Basic) | 81.19M | 64.33M | 41.93M | 24.27M | 7.87M | 7.35M |
| Shares Outstanding (Diluted) | 81.19M | 64.33M | 41.93M | 24.27M | 7.87M | 7.35M |
| EPS (Basic) | -0.65 | -0.76 | -0.76 | -0.82 | -2.35 | -2.03 |
| EPS (Diluted) | -0.65 | -0.76 | -0.76 | -0.82 | -2.35 | -2.03 |
| Free Cash Flow | -42.46M | -36.77M | -23.27M | -16.76M | -16.02M | -13.55M |
| Free Cash Flow Per Share | -0.52 | -0.57 | -0.56 | -0.69 | -2.03 | -1.84 |
| Gross Margin | 18.05% | 29.50% | 21.49% | 29.12% | 21.60% | 16.77% |
| Operating Margin | -494.03% | -552.56% | -478.00% | -340.74% | -361.88% | -327.39% |
| Profit Margin | -484.11% | -543.33% | -456.63% | -320.97% | -357.59% | -331.88% |
| Free Cash Flow Margin | -391.67% | -409.45% | -332.00% | -270.06% | -309.71% | -301.54% |
| EBITDA | -52.98M | -49.14M | -33.22M | -20.91M | -18.52M | -14.55M |
| D&A For EBITDA | 578.00K | 476.00K | 280.00K | 232.00K | 188.00K | 161.00K |
| EBIT | -53.56M | -49.61M | -33.50M | -21.14M | -18.71M | -14.72M |
| Advertising Expenses | 1.59M | 691.00K | 426.00K | 359.00K | 290.00K |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 15.15M | 8.94M | 18.92M | 9.64M | 4.63M | 12.00M |
| Short-Term Investments | 15.27M | 45.27M | 15.72M | 29.38M | 13.17M | 22.04M |
| Cash & Short-Term Investments | 30.42M | 54.21M | 34.64M | 39.02M | 17.80M | 34.04M |
| Accounts Receivable | 1.82M | 2.17M | 1.57M | 1.80M | 1.03M | 1.22M |
| Other Receivables | 592.00K | 400.00K | 682.00K | 648.00K | 213.00K | 165.00K |
| Receivables | 2.41M | 2.57M | 2.25M | 2.45M | 1.25M | 1.39M |
| Inventory | 2.70M | 3.40M | 2.57M | 2.11M | 1.62M | 1.14M |
| Prepaid Expenses | 1.10M | 1.30M | 1.06M | 578.00K | 655.00K | 522.00K |
| Total Current Assets | 36.63M | 61.47M | 40.52M | 44.16M | 21.33M | 37.09M |
| Property, Plant & Equipment | 6.29M | 6.34M | 4.73M | 2.53M | 2.47M | 1.71M |
| Other Long-Term Assets | 1.73M | 1.59M | 1.55M | 951.00K | 856.00K | 905.00K |
| Total Assets | 44.64M | 69.40M | 46.81M | 47.64M | 24.65M | 39.71M |
| Accounts Payable | 1.65M | 1.25M | 1.25M | 939.00K | 659.00K | 893.00K |
| Accrued Expenses | 6.05M | 8.05M | 5.63M | 4.33M | 3.86M | 2.88M |
| Current Portion of Leases | 1.06M | 1.07M | 542.00K | 557.00K | 419.00K | 420.00K |
| Other Current Liabilities | 885.00K | 336.00K | 255.00K | 190.00K | 130.00K | 155.00K |
| Total Current Liabilities | 9.65M | 10.71M | 7.68M | 6.02M | 5.07M | 4.35M |
| Long-Term Leases | 1.97M | 2.22M | 1.80M | 1.04M | 1.20M | 781.00K |
| Pension & Post-Retirement Benefits | 1.51M | 1.27M | 1.25M | 1.08M | 995.00K | 1.05M |
| Total Liabilities | 13.13M | 14.20M | 10.72M | 8.14M | 7.26M | 6.18M |
| Common Stock | 5.00K | 4.00K | 3.00K | 2.00K | 1.00K | 1.00K |
| Additional Paid-In Capital | 361.81M | 357.49M | 289.59M | 261.00M | 218.98M | 216.62M |
| Retained Earnings | -330.31M | -302.29M | -253.51M | -221.50M | -201.59M | -183.09M |
| Total Common Equity | 31.51M | 55.20M | 36.09M | 39.50M | 17.39M | 33.53M |
| Shareholders' Equity | 31.51M | 55.20M | 36.09M | 39.50M | 17.39M | 33.53M |
| Total Liabilities & Equity | 44.64M | 69.40M | 46.81M | 47.64M | 24.65M | 39.71M |
| Total Debt | 3.02M | 3.29M | 2.34M | 1.59M | 1.61M | 1.20M |
| Net Cash (Debt) | 27.40M | 50.92M | 32.30M | 37.43M | 16.19M | 32.84M |
| Net Cash Per Share | 0.34 | 0.79 | 0.77 | 1.54 | 2.06 | 4.47 |
| Filing Date Shares Outstanding | 46.49M | 46.80M | 29.69M | 23.46M | 8.33M | 8.32M |
| Total Common Shares Outstanding | 46.92M | 43.53M | 26.61M | 21.84M | 8.33M | 8.30M |
| Working Capital | 26.98M | 50.76M | 32.84M | 38.14M | 16.26M | 32.75M |
| Book Value Per Share | 0.67 | 1.27 | 1.36 | 1.81 | 2.09 | 4.04 |
| Tangible Book Value | 31.51M | 55.20M | 36.09M | 39.50M | 17.39M | 33.53M |
| Tangible Book Value Per Share | 0.67 | 1.27 | 1.36 | 1.81 | 2.09 | 4.04 |
| Machinery | 5.22M | 3.83M | 2.38M | 2.33M | 2.12M | |
| Leasehold Improvements | 1.09M | 861.00K | 724.00K | 494.00K | 243.00K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -52.48M | -48.79M | -32.01M | -19.92M | -18.49M | -14.92M |
| Depreciation & Amortization | 578.00K | 476.00K | 280.00K | 232.00K | 188.00K | 161.00K |
| Loss (Gain) From Sale of Assets | -14.00K | -14.00K | -6.00K | -1.00K | ||
| Loss (Gain) From Sale of Investments | -204.00K | -359.00K | -894.00K | -739.00K | ||
| Stock-Based Compensation | 10.71M | 12.33M | 10.14M | 4.49M | 2.35M | 1.58M |
| Other Operating Activities | -149.00K | 142.00K | -123.00K | 364.00K | 14.00K | 33.00K |
| Change in Accounts Receivable | -224.00K | -596.00K | 232.00K | -770.00K | 190.00K | -748.00K |
| Change in Inventory | 353.00K | -826.00K | -464.00K | -485.00K | -478.00K | 272.00K |
| Change in Accounts Payable | 136.00K | 1.00K | 315.00K | 280.00K | -234.00K | 657.00K |
| Change in Other Net Operating Assets | 81.00K | 2.53M | 653.00K | 174.00K | 917.00K | -242.00K |
| Operating Cash Flow | -41.21M | -35.10M | -21.87M | -16.38M | -15.54M | -13.21M |
| Capital Expenditures | -1.25M | -1.66M | -1.40M | -381.00K | -473.00K | -344.00K |
| Sale of Property, Plant & Equipment | 15.00K | 15.00K | 12.00K | |||
| Investment in Securities | -7.20M | -29.19M | 14.13M | -15.64M | 9.00M | -22.00M |
| Other Investing Activities | 287.00K | 279.00K | -87.00K | -79.00K | -86.00K | -113.00K |
| Investing Cash Flow | -8.15M | -30.56M | 12.64M | -16.09M | 8.44M | -22.46M |
| Issuance of Common Stock | 52.90M | 55.57M | 18.53M | 42.17M | 37.06M | |
| Other Financing Activities | 22.00K | -81.00K | -4.63M | -140.00K | -2.02M | |
| Financing Cash Flow | 52.93M | 55.57M | 18.45M | 37.53M | -140.00K | 35.03M |
| Foreign Exchange Rate Adjustments | 76.00K | 117.00K | 51.00K | -58.00K | -131.00K | -8.00K |
| Net Cash Flow | 3.64M | -9.98M | 9.28M | 5.01M | -7.37M | -641.00K |
| Free Cash Flow | -42.46M | -36.77M | -23.27M | -16.76M | -16.02M | -13.55M |
| Free Cash Flow Margin | -391.67% | -409.45% | -332.00% | -270.06% | -309.71% | -301.54% |
| Free Cash Flow Per Share | -0.52 | -0.57 | -0.56 | -0.69 | -2.03 | -1.84 |
| Levered Free Cash Flow | -23.11M | -18.73M | -11.00M | -9.67M | -9.37M | -7.64M |
| Unlevered Free Cash Flow | -23.11M | -18.73M | -11.00M | -9.67M | -9.37M | -7.54M |
| Change in Working Capital | 346.00K | 1.11M | 736.00K | -801.00K | 395.00K | -61.00K |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 24.47M | 75.42M | 68.60M | 60.13M | 7.16M | 24.39M |
| Enterprise Value | -2.92M | 15.39M | 29.43M | 18.70M | -12.20M | -11.44M |
| Last Close Price | 0.45 | 1.78 | 2.63 | 2.81 | 0.86 | 3.02 |
| Forward PE | 6.57 | 6.57 | 6.57 | 6.57 | 6.57 | |
| PS Ratio | 1.93 | 8.40 | 9.79 | 9.69 | 1.39 | 5.43 |
| PB Ratio | 0.67 | 1.37 | 1.90 | 1.52 | 0.41 | 0.73 |
| P/TBV Ratio | 0.66 | 1.37 | 1.90 | 1.52 | 0.41 | 0.73 |
| EV/Sales Ratio | 1.71 | 4.20 | 3.01 | |||
| Debt / Equity Ratio | 0.10 | 0.06 | 0.07 | 0.04 | 0.09 | 0.04 |
| Net Debt / Equity Ratio | -0.87 | -0.92 | -0.90 | -0.95 | -0.93 | -0.98 |
| Net Debt / EBITDA Ratio | 0.52 | 1.04 | 0.97 | 1.79 | 0.87 | 2.26 |
| Net Debt / FCF Ratio | 0.65 | 1.39 | 1.39 | 2.23 | 1.01 | 2.42 |
| Asset Turnover | 0.28 | 0.15 | 0.15 | 0.17 | 0.16 | 0.16 |
| Inventory Turnover | 3.09 | 2.12 | 2.35 | 2.36 | 2.93 | 2.92 |
| Quick Ratio | 3.40 | 5.30 | 4.80 | 6.89 | 3.76 | 8.15 |
| Current Ratio | 3.80 | 5.74 | 5.28 | 7.33 | 4.21 | 8.53 |
| Return on Equity (ROE) | -202.81% | -106.89% | -84.68% | -70.01% | -72.62% | -65.29% |
| Return on Assets (ROA) | -85.85% | -53.37% | -44.34% | -36.56% | -36.34% | -32.00% |
| Return on Capital Employed (ROCE) | -153.00% | -84.50% | -85.60% | -50.80% | -95.60% | -41.60% |
| Earnings Yield | -122.80% | -64.69% | -46.65% | -33.12% | -258.09% | -61.16% |
| FCF Yield | -202.97% | -48.75% | -33.92% | -27.87% | -223.53% | -55.57% |
| Buyback Yield / Dilution | -63.52% | -53.42% | -72.77% | -208.29% | -7.16% | -385.71% |